Astoria Portfolio Advisors’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-42,127
Closed -$993K 264
2025
Q1
$993K Sell
42,127
-25,121
-37% -$593K 0.34% 73
2024
Q4
$1.57M Buy
67,248
+10,893
+19% +$258K 0.56% 31
2024
Q3
$1.35M Buy
56,355
+269
+0.5% +$6.42K 0.46% 38
2024
Q2
$1.31M Buy
56,086
+8,867
+19% +$207K 0.47% 31
2024
Q1
$1.09M Buy
47,219
+9,534
+25% +$224K 0.42% 40
2023
Q4
$892K Sell
37,685
-7,076
-16% -$162K 0.36% 48
2023
Q3
$1M Sell
44,761
-1,474
-3% -$33.8K 0.49% 34
2023
Q2
$1.07M Buy
46,235
+2,329
+5% +$54.1K 0.42% 40
2023
Q1
$1.03M Buy
43,906
+371
+0.9% +$8.62K 0.44% 33
2022
Q4
$1.02M Buy
43,535
+4,201
+11% +$95.8K 0.48% 34
2022
Q3
$890K Buy
+39,334
New +$923K 0.6% 33

Other funds holding IBD

Astoria Portfolio Advisors's IBD Position: Q2 2025 in Review

Astoria Portfolio Advisors sold out of Inspire Corporate Bond ETF (IBD) in Q2 2025, closing a stake of 42,127 shares — an estimated $993K sold.

Astoria Portfolio Advisors first reported a position in IBD in Q3 2022 and held it in 11 quarters. The position peaked at $1.57M in Q4 2024. 94 funds tracked by Wall St. Rank hold IBD as of Q2 2025.

  • Astoria Portfolio Advisors reported no remaining Inspire Corporate Bond ETF position as of Q2 2025 after selling out during the quarter.
  • Astoria Portfolio Advisors sold 42,127 Inspire Corporate Bond ETF shares in Q2 2025, an estimated $993K.
  • Astoria Portfolio Advisors first reported a position in Inspire Corporate Bond ETF in Q3 2022 and held it in 11 quarters.
  • Astoria Portfolio Advisors's Inspire Corporate Bond ETF position peaked at $1.57M in Q4 2024.
  • 94 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2025.

Based on Astoria Portfolio Advisors's 13F filing for Q2 2025, filed 25 Jul 2025.